ArticleThe American journal of case reports2025
Ectopic Adrenocortical Adenoma Causing Malignant Hypertension and Hypokalemia.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Ectopic adrenocortical adenomas are rare and can produce aldosterone autonomously, causing resistant hypertension and hypokalemia. Atypical locations pose diagnostic challenges. This report describes a 45-year-old man with malignant hypertension and hypokalemia due to an aldosterone-producing ectopic adrenal adenoma located between the pancreas and left adrenal gland. CASE REPORT A 45-year-old man with a 9-year history of poorly controlled hypertension presented with dizziness, vomiting, and fatigue. On admission, blood pressure was 192/110 mmHg and serum potassium was 2.07 mmol/L. Physical examination revealed left ventricular hypertrophy and hypertensive end-organ damage. Laboratory test results showed elevated plasma aldosterone (47.61 ng/dL) and suppressed renin (0.04 ng/mL/h), yielding an aldosterone-to-renin ratio of 1190. Abdominal CT and MRI identified a 3-cm solid cystic mass between the pancreatic tail and lateral branch of the left adrenal gland. Cortisol circadian rhythm, dehydroepiandrosterone sulfate, and plasma metanephrines were within normal limits, excluding other functional adrenal tumors. The patient underwent complete surgical resection of the ectopic adrenal adenoma. Histopathology confirmed adrenal cortical adenoma with focal adrenal medullary hyperplasia. At 1-year follow-up, he had normal blood pressure and serum potassium levels on an antihypertensive regimen. CONCLUSIONS This case highlights a rare ectopic aldosterone-producing adrenal adenoma near the pancreas. A thorough biochemical and imaging workup was essential for diagnosis, and surgical resection achieved clinical resolution. Ectopic adrenal tumors should be considered in the differential diagnosis of resistant hypertension with hypokalemia when standard adrenal imaging is inconclusive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.